Hereditary renal cell carcinoma in the rat associated with nonrandom loss of chromosomes 5 and 6.

A spontaneous form of renal cell carcinoma occurs in rats that arises as the result of the inheritance of a mutation in a single autosomal gene. Cytogenetic analysis was performed on seven cell lines and four primary tumor cell preparations derived from this hereditary form of renal cell carcinoma. Banded karyotypes prepared from these seven lines exhibited loss and/or partial deletion of both chromosomes 5 and 6. Translocations involving chromosome 4, resulting in a net loss of genetic material located near the centromere (4q11), were observed in three of the cell lines. Monosomy, translocation, and breakage of chromosome 5 involving band 5q31 and monosomy and partial deletion of chromosome 6 involving band 6q22-q24 were independently observed in primary tumor cells from three of four tumors examined. Monosomy of chromosome 4 was observed in cells from a single tumor. The smallest region of deletion of chromosome 6 common to all the cell lines and tumor cells was 6q24, suggesting the presence of a tumor suppressor gene at this locus. These results indicate that loss of genes located on chromosomes 4, 5, and 6, possibly tumor suppressor gene(s), may be important for tumor development and/or progression in rat renal cell carcinoma and is consistent with the hypothesis that a gene locus on one of these chromosomes may be the site of the original predisposing mutation.

[1]  M. Genet,et al.  Assignment of 12 loci to rat chromosome 5: evidence that this chromosome is homologous to mouse chromosome 4 and to human chromosomes 9 and 1 (1p arm). , 1990, Genomics.

[2]  J. Minna,et al.  Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumors. , 1988, The Journal of clinical investigation.

[3]  R. Sager.  Tumor suppressor genes: the puzzle and the promise. , 1989, Science.

[4]  Y. Nakamura,et al.  Allelotype of colorectal carcinomas. , 1989, Science.

[5]  J. Rey,et al.  Cytogenetic findings in an effusion secondary from pleural mesothelioma. , 1987, Cancer genetics and cytogenetics.

[6]  R. Schinella,et al.  Cytogenetic, flow cytometric, and ultrastructural studies of twenty-nine nonfamilial human renal carcinomas. , 1988, Cancer research.

[7]  H. A. Solleveld,et al.  Spontaneous Renal Lesions in Five Rat Strains , 1986, Toxicologic pathology.

[8]  A. Sandberg,et al.  Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. , 1986, Cancer research.

[9]  J. Rowley.  Mapping of human chromosomal regions related to neoplasia: evidence from chromosomes 1 and 17. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Hard.  Experimental Models for the Sequential Analysis of Chemically-Induced Renal Carcinogenesis , 1986, Toxicologic pathology.

[11]  J. Testa,et al.  Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: Possible sites of tumor suppressor genes , 1989, Genes, chromosomes & cancer.

[12]  N. Bouck,et al.  Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Kovacs,et al.  Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. , 1989, Cancer research.

[14]  J. Mascarello,et al.  A dysmorphic child with myelodysplasia characterized by a duplication of 1q and multiple duplications of 3q. , 1989, Cancer genetics and cytogenetics.

[15]  J. V. Johannessen,et al.  Hereditary renal adenomas and adenocarcinomas in rats. , 1981, Diagnostic histopathology.

[16]  M Terada,et al.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  N C Dracopoli,et al.  Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Willey,et al.  Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Klinger.  Suppression of tumorigenicity. , 1982, Cytogenetics and cell genetics.

[20]  M. Yoshida,et al.  Regional mapping of the FOS oncogene to rat chromosome 6q21----q23. , 1989, Cytogenetics and cell genetics.

[21]  M. Oshimura,et al.  Concordant deletions of chromosome 3p and loss of heterozygosity for chromosomes 13 and 17 in small cell lung carcinoma. , 1989, Cancer research.

[22]  J. Osinga,et al.  Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer , 1987, Nature.

[23]  J. Rowley,et al.  Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. , 1985, The New England journal of medicine.

[24]  W. Graham.  Deletions of interferon genes in acute lymphoblastic leukemia. , 1990, The New England journal of medicine.

[25]  E. E. Gresch.  Genetic Alterations During Colorectal-Tumor Development , 1989 .

[26]  S. Knuutila,et al.  Nonrandom chromosomal abnormalities in malignant pleural mesothelioma. , 1988, Cancer genetics and cytogenetics.

[27]  Y. Nakamura,et al.  Specific genetic change in tumors associated with von Hippel-Lindau disease. , 1989, Journal of the National Cancer Institute.

[28]  D. Housman,et al.  Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. DiPaolo,et al.  Nonrandom chromosome alterations in human malignant mesothelioma. , 1988, Cancer research.

[30]  A. Gazdar,et al.  Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Stahel,et al.  Chromosome changes in malignant mesothelioma. , 1986, Cancer genetics and cytogenetics.

[32]  D. Albertson,et al.  Frequency and extent of allelic loss in the short arm of chromosome 3 in nonsmall‐cell lung cancer , 1989, Genes, chromosomes & cancer.

[33]  G. Levan,et al.  The gene map of the Norway rat (Rattus norvegicus) and comparative mapping with mouse and man. , 1991, Genomics.

[34]  G. Kovacs.  Preferential involvement of chromosome 1q in a primary breast carcinoma. , 1981, Cancer Genetics and Cytogenetics.

[35]  J. Minna,et al.  Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). , 1982, Science.

[36]  M. Oshimura,et al.  Induction of cellular senescence in immortalized cells by human chromosome 1. , 1990, Science.

[37]  G. Klein,et al.  Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Levan,et al.  A gene for the suppression of anchorage independence is located in rat chromosome 5 bands q22-23, and the rat alpha-interferon locus maps at the same region. , 1989, Journal of cell science.

[39]  N. B. Atkin,et al.  Chromosome changes in early gynecologic malignancies. , 1983, Acta cytologica.

[40]  A. Knudson.  Hereditary cancer, oncogenes, and antioncogenes. , 1985, Cancer research.

[41]  L. Strong,et al.  Familial renal cell carcinoma with a 3;11 chromosome translocation limited to tumor cells. , 1982, Science.

[42]  S. Jacobs,et al.  Hereditary renal-cell carcinoma associated with a chromosomal translocation. , 1979, The New England journal of medicine.

[43]  R. Weinberg.  The molecular basis of retinoblastomas. , 1989, Ciba Foundation symposium.

[44]  C. Mathew,et al.  Deletion of genes on chromosome 1 in endocrine neoplasia , 1987, Nature.

[45]  A. Kiss,et al.  Abnormalities of chromosome 1 in relation to human malignant diseases. , 1989, Cancer genetics and cytogenetics.

[46]  J. Mossige,et al.  A Dominant Gene for Renal Adenomas in the Rat , 1961, Nature.

[47]  M. Yoshida,et al.  Differential Staining of Parental Chromosomes in Interspecific Cell Hybrids with a Combined Quinacrine and 33258 Hoechst Technique , 1975 .

[48]  A. Dobrovic,et al.  erbA-related sequence coding for DNA-binding hormone receptor localized to chromosome 3p21-3p25 and deleted in small cell lung carcinoma. , 1988, Cancer research.

[49]  Y. Tachibana,et al.  Rearrangements of Chromosome 3 in Nonfamilial Renal Cell Carcinomas from Japanese Patients , 1988, Japanese journal of cancer research : Gann.

[50]  K. Michalski,et al.  Cytogenetic analysis in renal cell carcinoma: correlation with tumor aggressiveness. , 1988, Cancer research.